FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 171 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $393,000 | -9.7% | 25,305 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $435,000 | -21.6% | 25,305 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $555,000 | -43.8% | 25,305 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $988,000 | +29.7% | 25,305 | +66.5% | 0.00% | +100.0% |
| Q4 2016 | $762,000 | -4.5% | 15,198 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $798,000 | +27.1% | 15,198 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $628,000 | – | 15,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|